{"gene":"ADIPOQ","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1995,"finding":"Acrp30 (ADIPOQ) is a novel 30-kDa secretory protein made exclusively in adipocytes, forming large homo-oligomers that undergo post-translational modifications; its secretion is enhanced by insulin, identifying it as an abundant serum protein with structural similarity to complement factor C1q.","method":"Differential display cloning, Western blot, oligomer characterization, insulin stimulation assay in adipocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — original discovery with multiple orthogonal methods, highly cited foundational paper","pmids":["7592907"],"is_preprint":false},{"year":1996,"finding":"AdipoQ encodes a 247-amino-acid secreted protein with a signal sequence, collagenous (Gly-X-Y) region, and a C1q-like globular domain; expression is adipose-specific and restricted to mature adipocytes, and is significantly reduced in obese mice and humans.","method":"mRNA differential display, cDNA cloning, Northern blot, in situ hybridization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — original cloning with multiple expression methods, highly cited foundational paper","pmids":["8631877"],"is_preprint":false},{"year":1996,"finding":"GBP28 (ADIPOQ) is a gelatin-binding plasma protein purified from human plasma; on SDS-PAGE it migrates as 28 kDa (reducing) or 68 kDa (non-reducing), and by gel chromatography as ~420 kDa, indicating disulfide-linked oligomeric complexes.","method":"Affinity chromatography (gelatin-Cellulofine), gel filtration, SDS-PAGE, N-terminal sequencing","journal":"Journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical purification and characterization of protein from human plasma","pmids":["8947845"],"is_preprint":false},{"year":1999,"finding":"ADIPOQ (adiponectin) in 3T3-L1 adipocytes is stored in a regulated secretory compartment distinct from GLUT4 vesicles; insulin-stimulated secretion of ACRP30 requires phosphatidylinositol-3-kinase activity, and ACRP30 and GLUT4 occupy non-overlapping intracellular compartments.","method":"Deconvolution immunofluorescence microscopy, PI3K inhibitor (wortmannin/LY294002) treatment, insulin stimulation, secretion assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — direct imaging and pharmacological dissection in adipocytes","pmids":["10444069"],"is_preprint":false},{"year":1999,"finding":"Adiponectin inhibits TNF-α-induced expression of endothelial adhesion molecules (VCAM-1, E-selectin, ICAM-1) and monocyte adhesion to human aortic endothelial cells at physiological concentrations.","method":"Cell ELISA, adhesion assay with THP-1 cells, treatment of HAECs with recombinant adiponectin","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — direct in vitro functional assay with primary endothelial cells, highly cited","pmids":["10604883"],"is_preprint":false},{"year":2000,"finding":"Adiponectin inhibits TNF-α-induced NF-κB activation in endothelial cells by suppressing IκB-α phosphorylation through a cAMP/PKA-dependent pathway; it specifically binds HAECs in a saturable manner without affecting TNF-α receptor interaction.","method":"Cell ELISA with biotinylated adiponectin, EMSA (NF-κB binding), immunoblotting (IκB-α phosphorylation), adenylate cyclase and PKA inhibitors, cAMP measurement","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal mechanistic methods, highly cited","pmids":["10982546"],"is_preprint":false},{"year":2000,"finding":"Adiponectin suppresses macrophage-to-foam cell transformation by reducing class A scavenger receptor (MSR) expression at mRNA and protein levels via decreased MSR promoter activity, without affecting CD36 expression; it also inhibits macrophage phagocytosis via the complement receptor C1qRp.","method":"Cholesteryl ester assay, Oil Red O staining, Northern blot, immunoblot, luciferase reporter assay, flow cytometry, anti-C1qRp antibody blockade","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including reporter assay and receptor blockade","pmids":["11222466"],"is_preprint":false},{"year":2000,"finding":"Adiponectin suppresses growth of myelomonocytic progenitors and induces apoptosis (subdiploid peaks, oligonucleosomal DNA fragmentation) in acute myelomonocytic leukemia lines; it also suppresses macrophage phagocytosis and LPS-induced TNF-α production, partly via the C1q receptor C1qRp.","method":"Colony formation assay, flow cytometry (sub-G1), DNA fragmentation assay, anti-C1qRp antibody blockade, TNF-α ELISA","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple functional assays with defined receptor blockade","pmids":["10961870"],"is_preprint":false},{"year":2001,"finding":"A single injection of recombinant Acrp30 in mice causes a 2–3-fold elevation in circulating levels and transiently lowers basal glucose; in isolated hepatocytes, Acrp30 enhances sub-physiological insulin-mediated suppression of glucose production, identifying the liver as a primary target organ.","method":"Recombinant protein injection in mice (ob/ob, NOD, STZ-treated), isolated hepatocyte glucose production assay","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — in vivo and ex vivo mechanistic assays, highly cited","pmids":["11479628"],"is_preprint":false},{"year":2001,"finding":"Adiponectin reverses insulin resistance in both obese and lipoatrophic mouse models by decreasing triglyceride content in muscle and liver through increased expression of fatty-acid combustion and energy dissipation molecules; combination of adiponectin and leptin fully reverses lipoatrophic insulin resistance.","method":"Recombinant adiponectin administration, triglyceride content assay in muscle/liver, gene expression profiling, adiponectin+leptin co-treatment in lipoatrophic mice","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple in vivo models with defined molecular readouts, 3832 citations","pmids":["11479627"],"is_preprint":false},{"year":2001,"finding":"Intraperitoneal Acrp30 infusion during a euglycemic clamp reduces hepatic glucose production by 65% and decreases expression of gluconeogenic enzymes PEPCK and G6Pase by >50%, without affecting peripheral glucose uptake or glycolysis.","method":"Pancreatic euglycemic clamp in conscious mice, glucose flux measurement, hepatic mRNA analysis (PEPCK, G6Pase)","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — rigorous in vivo clamp study with molecular readouts","pmids":["11748271"],"is_preprint":false},{"year":2002,"finding":"Adiponectin activates AMP-activated protein kinase (AMPK) in skeletal muscle (both globular and full-length forms) and liver (full-length only), leading to phosphorylation of ACC, increased fatty-acid oxidation and glucose uptake; dominant-negative AMPK blocks all these effects.","method":"AMPK phosphorylation assay, ACC phosphorylation, fatty-acid oxidation assay, glucose uptake assay, dominant-negative AMPK mutant transfection in myocytes and hepatocytes","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 1–2 — loss-of-function genetic epistasis with dominant-negative, multiple orthogonal assays, 3297 citations","pmids":["12368907"],"is_preprint":false},{"year":2002,"finding":"Adiponectin-knockout mice show severe diet-induced insulin resistance with reduced IRS-1-associated PI3-kinase activity in muscle, elevated TNF-α in adipose tissue, delayed FFA clearance, and reduced muscle FATP-1 mRNA; viral re-expression of adiponectin reverses these defects.","method":"Gene knockout, PI3K activity assay, TNF-α mRNA measurement, FATP-1 mRNA, FFA clearance, viral rescue experiment in KO mice","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — KO with rescue experiment and defined molecular pathway readouts","pmids":["12068289"],"is_preprint":false},{"year":2002,"finding":"Acrp30 oligomer formation critically depends on disulfide bond formation via Cys-39; mutation of Cys-39 results in trimers that are more bioactive than higher-order oligomers with respect to lowering serum glucose and reducing hepatocyte glucose output; females display higher HMW complex levels than males.","method":"Mutagenesis (Cys-39 to Ser), DTT reduction, in vivo glucose measurement, primary hepatocyte glucose output assay, non-denaturing SDS-PAGE","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — structure-function mutagenesis with in vivo and ex vivo bioactivity validation","pmids":["12496257"],"is_preprint":false},{"year":2002,"finding":"Only hexameric and higher-MW forms of Acrp30 activate NF-κB (via IκB-α phosphorylation/degradation) in C2C12 myocytes; trimeric Acrp30 does not activate NF-κB, demonstrating oligomerization state-dependent signaling specificity.","method":"NF-κB reporter assay, IκB-α phosphorylation by immunoblot, purified trimers and hexamers from E. coli and 293T cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — defined oligomeric fractions tested in parallel with NF-κB reporter","pmids":["12087086"],"is_preprint":false},{"year":2003,"finding":"Cloning of AdipoR1 (abundant in skeletal muscle) and AdipoR2 (predominant in liver) by expression cloning; both receptors have seven transmembrane domains but are structurally and functionally distinct from GPCRs; they mediate globular and full-length adiponectin binding and downstream AMPK and PPARα activation, fatty-acid oxidation, and glucose uptake.","method":"Expression cloning from C2C12 cDNA library, siRNA knockdown, AMPK/PPARα activity assays, fatty-acid oxidation, glucose uptake","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — expression cloning with siRNA loss-of-function and multiple functional readouts, 2514 citations","pmids":["12802337"],"is_preprint":false},{"year":2003,"finding":"Trimeric and HMW/hexameric Acrp30 activate distinct signal transduction pathways: trimers activate AMPK (Thr172 phosphorylation) in muscle; HMW and hexamers activate NF-κB in C2C12 cells; Cys-22 disulfide bonds are required for hexamer and HMW assembly but not trimer stability.","method":"Freeze-etch electron microscopy, DTT reduction, Cys22Ala mutagenesis, AMPK phosphorylation assay (rat EDL muscle), NF-κB reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — structural EM plus mutagenesis plus multiple functional assays","pmids":["14522956"],"is_preprint":false},{"year":2003,"finding":"The ratio of HMW to LMW adiponectin (S_A index), not absolute total adiponectin, correlates with insulin sensitivity; HMW adiponectin complex is the active form in vivo (dose-dependently lowers serum glucose), primarily acting on hepatic insulin sensitivity.","method":"Non-denaturing SDS-PAGE oligomer separation, euglycemic clamp, in vivo glucose infusion with defined oligomeric fractions in db/db mice and human cohorts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vivo dose-response with defined oligomeric fractions plus human clinical validation","pmids":["14699128"],"is_preprint":false},{"year":2003,"finding":"Adiponectin stimulates NO production in vascular endothelial cells via a PI3K-dependent pathway involving phosphorylation of Akt (Ser473) and eNOS (Ser1179) by AMPK; dominant-negative AMPK (but not dominant-negative Akt) inhibits adiponectin-induced eNOS phosphorylation and NO production.","method":"DAF-2 DA fluorescent NO assay, phospho-specific immunoblotting, wortmannin inhibition, dominant-negative AMPK and Akt transfection in bovine aortic endothelial cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — loss-of-function genetic epistasis with multiple orthogonal methods","pmids":["12944390"],"is_preprint":false},{"year":2003,"finding":"Adiponectin mutations G84R and G90S (associated with diabetes) fail to form HMW multimers; R112C and I164T mutants fail to assemble into trimers and show impaired secretion; an N-terminal Cys-to-Ser mutation abolishing multimers >trimers abrogates AMPK pathway activation in hepatocytes.","method":"Non-reducing/non-heat-denaturing SDS-PAGE, site-directed mutagenesis, transfection in NIH-3T3 cells, AMPK pathway assay in hepatocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — structure-function mutagenesis correlated with functional AMPK assay","pmids":["12878598"],"is_preprint":false},{"year":2003,"finding":"Adiponectin stimulates angiogenesis in vitro (HUVEC capillary differentiation and migration) and in vivo (Matrigel plug and corneal models) via cross-talk between AMPK and Akt signaling, both required for eNOS phosphorylation; dominant-negative AMPK blocks adiponectin-induced Akt phosphorylation, placing AMPK upstream of Akt.","method":"HUVEC tube formation, migration assay, dominant-negative AMPK and Akt transfection, phospho-immunoblotting, in vivo Matrigel and corneal angiogenesis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in vitro confirmed by in vivo models","pmids":["14557259"],"is_preprint":false},{"year":2003,"finding":"PPARγ/RXR heterodimer directly binds a functional PPAR-responsive element (PPRE) in the human adiponectin promoter to drive transcription; LRH-1 binds a separate responsive element and augments PPARγ-induced transactivation; point mutations in either element markedly reduce basal and TZD-induced adiponectin promoter activity.","method":"Promoter deletion/mutation analysis, luciferase reporter assay, EMSA (direct binding), TZD treatment of 3T3-L1 and rat adipocytes","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1 — direct DNA-binding demonstrated by EMSA plus mutagenesis in multiple cell systems","pmids":["12829629"],"is_preprint":false},{"year":2003,"finding":"Adiponectin induces anti-inflammatory cytokines IL-10 and IL-1RA and suppresses IFN-γ production in primary human monocytes, macrophages, and dendritic cells; adiponectin-treated macrophages show reduced phagocytotic and allo-stimulatory capacity.","method":"Primary human monocyte/macrophage/DC culture, cytokine ELISA, phagocytosis assay, mixed lymphocyte reaction","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 — multiple primary cell types with functional readouts","pmids":["15369797"],"is_preprint":false},{"year":2004,"finding":"T-cadherin (a GPI-anchored extracellular protein expressed on endothelial and smooth muscle cells) acts as a receptor specifically for hexameric and HMW forms of adiponectin (not trimer or globular forms); binding requires eukaryotic post-translational modifications of adiponectin and the N-terminal cysteine required for hexamer/HMW formation.","method":"Retroviral cDNA expression library screening on adiponectin-coated magnetic beads in Ba/F3 cells, co-immunoprecipitation, binding assays with oligomeric fractions, Cys-mutant adiponectin","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — expression cloning plus co-IP with defined mutants","pmids":["15210937"],"is_preprint":false},{"year":2004,"finding":"Adiponectin induces endothelial cell apoptosis (caspase-8, -9, -3 cascade activation) as a mechanism of anti-angiogenesis; in a mouse tumor model, adiponectin inhibits primary tumor growth by reducing neovascularization and increasing tumor cell apoptosis.","method":"Endothelial cell proliferation/migration assay, chick CAM assay, mouse corneal angiogenesis, caspase activation assays, mouse tumor model with neovascularization quantification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — defined caspase cascade in vitro confirmed in vivo tumor model","pmids":["14983034"],"is_preprint":false},{"year":2005,"finding":"The v-SNARE Vti1a is a component of insulin-sensitive GLUT4-containing vesicles in adipocytes; siRNA-mediated depletion of Vti1a significantly inhibits both adiponectin (ACRP30) secretion and insulin-stimulated glucose uptake, indicating Vti1a regulates a step common to GLUT4 and ACRP30 trafficking.","method":"Proteomics (mass spectrometry) of purified GLUT4 membranes, siRNA knockdown, adiponectin secretion assay, deoxyglucose uptake assay in 3T3-L1 adipocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — siRNA loss-of-function with two orthogonal functional readouts","pmids":["16131485"],"is_preprint":false},{"year":2006,"finding":"ACRP30 secretion from 3T3-L1 adipocytes is routed through Rab11-positive recycling endosomes; dominant-negative Rab11-S25N and endosome ablation reduce basal and insulin-stimulated ACRP30 secretion; Arf6 also contributes to this secretory pathway.","method":"Dominant-negative Rab11 overexpression, endosome ablation, Brefeldin A treatment, co-localization with transferrin receptor (endosomal marker), secretion assay in 3T3-L1 adipocytes","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — dominant-negative approach with functional secretion readout, single lab","pmids":["16516854"],"is_preprint":false},{"year":2008,"finding":"APPL1, an adaptor protein with PTB domain, directly interacts with the intracellular regions of AdipoR1 and AdipoR2 and mediates adiponectin signaling, including AMPK activation and insulin sensitization in skeletal muscle; APPL1 is also required for adiponectin's anti-inflammatory and cytoprotective effects in endothelial cells.","method":"Co-immunoprecipitation, PTB domain binding assay, AMPK activity assay, glucose uptake in skeletal muscle, endothelial cell survival assay with APPL1 knockdown/overexpression","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 2 — direct protein-protein interaction with loss-of-function functional readouts, independently replicated","pmids":["18854421"],"is_preprint":false},{"year":2009,"finding":"Niacin stimulates adiponectin secretion through the GPR109A receptor via a pertussis toxin-sensitive (Gi) pathway; GPR109A knockout mice fail to increase adiponectin in response to niacin, and the effect is mimicked by β-hydroxybutyrate (endogenous GPR109A ligand) in primary adipocytes.","method":"In vivo niacin administration in rats and GPR109A-KO mice, primary adipocyte stimulation with pertussis toxin pretreatment, adiponectin ELISA, 3T3-L1 cell controls (low GPR109A expression)","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 2 — knockout mouse model plus pharmacological Gi inhibition, validated in multiple systems","pmids":["19141678"],"is_preprint":false},{"year":2010,"finding":"AdipoR1 forms homodimers via a GxxxG motif in the fifth transmembrane domain; mutation of both glycines (to Phe or Glu) modulates dimerization; adiponectin decreases AdipoR1 dimerization in a concentration-dependent manner, primarily through its collagen-like domain.","method":"Bimolecular fluorescence complementation (BiFC), flow cytometry, GxxxG mutagenesis, endogenous AdipoR1 dimer detection in cell lines and human muscle tissue","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1–2 — direct visualization of dimerization with mutagenesis and ligand dose-response","pmids":["20332107"],"is_preprint":false},{"year":2012,"finding":"Caveolin-3 is required for AdipoR1/Cav-3 complex formation via Cav-3 scaffolding domain motifs; AdipoR1/Cav-3 interaction is necessary for adiponectin-initiated AMPK-dependent and AMPK-independent (adenylate cyclase/PKA) cardioprotective signaling; APPL1 and adenylate cyclase form a complex with AdipoR1 in a Cav-3-dependent fashion.","method":"Co-immunoprecipitation, Cav-3 knockout mice (ischemia/reperfusion injury), infarct size measurement, AMPK activity assay, PKA inhibitor studies","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — KO mouse model with co-IP and defined signaling cascade dissection","pmids":["22328772"],"is_preprint":false},{"year":2015,"finding":"Osteocalcin (GluOC) induces adiponectin expression in adipocytes via GPRC6A receptor → cAMP → PKA → Src → Rap1 → ERK → CREB → PPARγ → adiponectin; U0126 (ERK inhibitor) and GPRC6A blockade attenuate CREB phosphorylation and adiponectin induction.","method":"Intracellular cAMP measurement, PKA activity, phospho-ERK/CREB immunoblot, U0126 inhibition, PPARγ luciferase reporter, intermittent GluOC oral administration in mice","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 2 — multi-step pathway validated with inhibitors and in vivo confirmation","pmids":["25562427"],"is_preprint":false},{"year":2015,"finding":"Adiponectin protects mdx (Duchenne muscular dystrophy) mice via AdipoR1 and the AMPK-SIRT1-PGC-1α pathway, reducing NF-κB activation and inflammatory genes while upregulating utrophin A; adiponectin null mice have markedly reduced circulating adiponectin in the dystrophic context.","method":"mdx × adiponectin-transgenic cross, in vivo force measurement, Evans Blue Dye muscle damage assay, AMPK/SIRT1/PGC-1α immunoblot, NF-κB reporter, human myotube culture","journal":"Skeletal muscle","confidence":"High","confidence_rationale":"Tier 2 — genetic mouse model with defined molecular pathway and functional phenotype","pmids":["26257862"],"is_preprint":false},{"year":2021,"finding":"Adiponectin null mice display exacerbated age-related glucose and lipid metabolism disorders and significantly shortened lifespan; transgenic mice with elevated circulating adiponectin show improved systemic insulin sensitivity, reduced age-related tissue inflammation and fibrosis, and prolonged healthspan and median lifespan.","method":"Adiponectin knockout and transgenic overexpression mouse models, glucose/lipid tolerance tests, tissue fibrosis quantification, lifespan analysis on chow and HFD","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — bidirectional genetic models (KO and overexpression) with defined metabolic and lifespan phenotypes","pmids":["33904399"],"is_preprint":false}],"current_model":"ADIPOQ (adiponectin/Acrp30) is an adipocyte-specific secreted hormone that circulates as trimers, hexamers, and high-molecular-weight (HMW) oligomers assembled via N-terminal disulfide bonds; HMW oligomers exert primary metabolic activity and bind T-cadherin and AdipoR1/R2, while trimers preferentially activate AMPK in muscle; upon binding AdipoR1 (muscle) or AdipoR2 (liver), adiponectin activates AMPK (phosphorylating ACC), increases fatty-acid oxidation and glucose uptake, suppresses hepatic gluconeogenesis (PEPCK, G6Pase), stimulates eNOS-mediated NO production via AMPK→Akt, inhibits NF-κB via cAMP/PKA, reduces macrophage scavenger receptor expression, and induces IL-10/IL-1RA; intracellular signaling is further regulated by the adaptor APPL1 (which binds AdipoR1/2 cytoplasmic domains) and by caveolin-3 scaffolding; adiponectin secretion from adipocytes is insulin-stimulated and routed through PI3K-dependent, Rab11/Arf6-regulated recycling endosomes, and is transcriptionally driven by PPARγ/RXR binding a functional PPRE in the ADIPOQ promoter."},"narrative":{"teleology":[{"year":1995,"claim":"Identification of Acrp30/adiponectin as a novel adipocyte-exclusive secreted protein that forms oligomers and is insulin-regulated established the existence of a major adipokine, opening the question of its physiological function.","evidence":"Differential display cloning, Western blot, oligomer characterization, and insulin stimulation in 3T3-L1 adipocytes","pmids":["7592907"],"confidence":"High","gaps":["Biological function unknown","Receptor(s) unidentified","Relevance of oligomeric forms unclear"]},{"year":1996,"claim":"Cloning of the full-length cDNA and demonstration that adiponectin expression is reduced in obesity linked the protein to metabolic disease and defined its domain architecture (signal peptide, collagenous domain, C1q-like globular domain).","evidence":"mRNA differential display, cDNA cloning, Northern blot in obese vs. lean mice and humans; biochemical purification from human plasma confirming disulfide-linked ~420 kDa oligomers","pmids":["8631877","8947845"],"confidence":"High","gaps":["Mechanism of obesity-associated downregulation unknown","No receptor identified","Whether oligomerization is functionally important untested"]},{"year":1999,"claim":"Demonstration that adiponectin resides in a PI3K-dependent regulated secretory compartment distinct from GLUT4 vesicles revealed that adipocytes actively control adiponectin release; concurrent discovery that adiponectin inhibits TNF-α-induced endothelial adhesion molecules established its anti-inflammatory vascular role.","evidence":"Deconvolution microscopy and PI3K inhibitors in 3T3-L1 adipocytes; cell ELISA and monocyte adhesion assay in HAECs","pmids":["10444069","10604883"],"confidence":"High","gaps":["Downstream endothelial signaling pathway unknown","Secretory compartment identity (recycling endosome vs. other) undefined"]},{"year":2000,"claim":"Elucidation of the cAMP/PKA-dependent mechanism by which adiponectin suppresses NF-κB (IκB-α phosphorylation) in endothelial cells, and of its ability to reduce macrophage foam-cell formation by downregulating class A scavenger receptor transcription, established the molecular basis for its anti-atherogenic activity.","evidence":"EMSA, IκB-α immunoblot, adenylate cyclase/PKA inhibitors in HAECs; scavenger receptor promoter reporter assay, Oil Red O staining, and C1qRp blockade in macrophages","pmids":["10982546","11222466","10961870"],"confidence":"High","gaps":["Identity of the endothelial receptor unknown","Whether C1qRp is a bona fide signaling receptor or merely a binding partner unresolved"]},{"year":2001,"claim":"In vivo studies showed adiponectin suppresses hepatic glucose production (reducing PEPCK and G6Pase) and reverses insulin resistance in obese and lipoatrophic mice by decreasing tissue triglyceride content, establishing the liver and muscle as primary metabolic target organs.","evidence":"Recombinant adiponectin injection in ob/ob, NOD, and STZ mice; euglycemic clamp; isolated hepatocyte glucose output; triglyceride content assays in muscle/liver","pmids":["11479628","11748271","11479627"],"confidence":"High","gaps":["Downstream kinase mediating hepatic effects unknown","Receptor identity still missing"]},{"year":2002,"claim":"AMPK was identified as the central kinase mediating adiponectin's metabolic effects — phosphorylating ACC to increase fatty-acid oxidation and glucose uptake — with dominant-negative AMPK blocking all effects; concurrently, adiponectin-knockout mice confirmed in vivo necessity for insulin sensitivity, and structure–function studies showed Cys-39-dependent disulfide bonds govern oligomer assembly and differential bioactivity of trimers vs. HMW forms.","evidence":"Dominant-negative AMPK in myocytes/hepatocytes; AMPK/ACC phosphorylation assays; adiponectin-KO mice with viral rescue; Cys-39 mutagenesis with in vivo glucose and hepatocyte glucose output assays; NF-κB reporter with purified oligomeric fractions","pmids":["12368907","12068289","12496257","12087086"],"confidence":"High","gaps":["Receptor still unidentified","How different oligomers are directed to different receptors unknown","Intracellular adaptor proteins linking receptor to AMPK not discovered"]},{"year":2003,"claim":"Expression cloning identified AdipoR1 and AdipoR2 as seven-transmembrane adiponectin receptors mediating AMPK and PPARα activation; T-cadherin was later found as a receptor for hexameric/HMW forms; the AMPK→Akt→eNOS cascade was defined as the mechanism for adiponectin-stimulated NO production and angiogenesis; and PPARγ/RXR binding to a PPRE in the ADIPOQ promoter established the transcriptional regulation of adiponectin itself.","evidence":"Expression cloning with siRNA in C2C12 cells; dominant-negative AMPK/Akt epistasis in endothelial cells; EMSA and promoter mutagenesis in adipocytes; retroviral library screen for T-cadherin","pmids":["12802337","12944390","12829629","15210937","14522956"],"confidence":"High","gaps":["T-cadherin lacks an intracellular domain — signaling mechanism downstream of T-cadherin unknown","Relative contributions of AdipoR1 vs. AdipoR2 to each tissue response not fully delineated"]},{"year":2006,"claim":"Routing of adiponectin secretion through Rab11-positive recycling endosomes (with Arf6 contribution) and v-SNARE Vti1a defined the intracellular trafficking pathway controlling adiponectin release from adipocytes.","evidence":"Dominant-negative Rab11, endosome ablation, and Brefeldin A in 3T3-L1 adipocytes; siRNA knockdown of Vti1a with secretion and glucose uptake assays","pmids":["16516854","16131485"],"confidence":"Medium","gaps":["Dominant-negative Rab11 approach not validated by knockout or rescue","Whether Vti1a acts on the same or parallel pathway as Rab11 unclear","Molecular machinery sorting adiponectin into recycling endosomes not identified"]},{"year":2008,"claim":"Identification of APPL1 as a direct adaptor bridging AdipoR1/R2 intracellular domains to AMPK activation and insulin sensitization resolved how receptor engagement couples to downstream kinase cascades.","evidence":"Co-immunoprecipitation, PTB domain binding, APPL1 knockdown/overexpression with AMPK activity and glucose uptake readouts in skeletal muscle and endothelial cells","pmids":["18854421"],"confidence":"High","gaps":["Whether APPL1 is the sole or one of multiple adaptors unknown","Crystal structure of AdipoR–APPL1 complex not resolved"]},{"year":2012,"claim":"Caveolin-3 was shown to scaffold the AdipoR1–APPL1–adenylate cyclase complex, enabling both AMPK-dependent and AMPK-independent (PKA) cardioprotective signaling, thereby adding a membrane microdomain requirement to the adiponectin signaling model.","evidence":"Co-IP and Cav-3 knockout mice with ischemia/reperfusion injury, infarct size measurement, PKA inhibitor studies","pmids":["22328772"],"confidence":"High","gaps":["Whether Cav-3 scaffolding applies to non-cardiac tissues (e.g. skeletal muscle, endothelium) not tested","Role of lipid raft disruption vs. Cav-3 protein specifically not distinguished"]},{"year":2015,"claim":"Osteocalcin was identified as an upstream inducer of adiponectin transcription via GPRC6A→cAMP→PKA→ERK→CREB→PPARγ, establishing a bone–adipose endocrine axis; separately, adiponectin was shown to protect dystrophic muscle through AdipoR1–AMPK–SIRT1–PGC-1α signaling.","evidence":"Pharmacological pathway dissection with U0126 and PPARγ reporter in adipocytes; mdx × adiponectin-transgenic mice with force measurement and Evans Blue Dye assay","pmids":["25562427","26257862"],"confidence":"High","gaps":["Whether osteocalcin–adiponectin axis is quantitatively relevant in humans unknown","Whether SIRT1–PGC-1α axis is engaged in non-dystrophic muscle contexts unclear"]},{"year":2021,"claim":"Bidirectional genetic models (knockout and transgenic overexpression) demonstrated that adiponectin is necessary and sufficient for metabolic healthspan: deficiency shortens lifespan with accelerated inflammation and fibrosis, while elevation extends median lifespan.","evidence":"Adiponectin-KO and adiponectin-overexpressing mice on chow and HFD, glucose/lipid tolerance, tissue fibrosis quantification, lifespan analysis","pmids":["33904399"],"confidence":"High","gaps":["Specific tissue(s) responsible for lifespan extension not identified","Whether chronic adiponectin elevation has detrimental effects in other contexts (e.g. cancer) not addressed"]},{"year":null,"claim":"How T-cadherin, which lacks an intracellular domain, transduces hexameric/HMW adiponectin signals remains mechanistically unresolved; the structural basis of oligomer-specific receptor selectivity and the full spectrum of tissue-specific adaptor complexes downstream of AdipoR1/R2 are also unknown.","evidence":"","pmids":[],"confidence":"Low","gaps":["T-cadherin signaling mechanism completely undefined","No crystal structure of full-length AdipoR–adiponectin complex","Relative in vivo contributions of AdipoR1, AdipoR2, and T-cadherin to specific metabolic outcomes not genetically dissected in parallel"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,1,8,9,11]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,6,11,18]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,2,17]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3,26]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[26]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,11,15,18,27,30]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[9,10,11,12]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,5,6,7,22]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,13,16]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[11,12]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[3,25,26]}],"complexes":[],"partners":["ADIPOR1","ADIPOR2","CDH13","APPL1","CAV3","VTI1A"],"other_free_text":[]},"mechanistic_narrative":"Adiponectin (ADIPOQ) is an abundant adipocyte-derived secreted hormone that circulates as disulfide-linked trimers, hexamers, and high-molecular-weight (HMW) multimers, each oligomeric species activating distinct signaling cascades: trimers preferentially stimulate AMPK in skeletal muscle to increase fatty-acid oxidation and glucose uptake, while HMW/hexameric forms act on the liver to suppress gluconeogenesis (PEPCK, G6Pase) and activate NF-κB in myocytes [PMID:12368907, PMID:14699128, PMID:14522956]. Adiponectin signals through the seven-transmembrane receptors AdipoR1 (muscle) and AdipoR2 (liver), scaffolded by caveolin-3 and the adaptor APPL1, to activate AMPK→ACC, AMPK→Akt→eNOS (NO production), and cAMP/PKA pathways, thereby exerting insulin-sensitizing, anti-inflammatory, and vasoprotective effects [PMID:12802337, PMID:18854421, PMID:22328772, PMID:12944390]. In the vasculature, adiponectin suppresses TNF-α-induced endothelial adhesion molecule expression via cAMP/PKA-dependent inhibition of NF-κB, reduces macrophage scavenger receptor expression to prevent foam-cell formation, and induces anti-inflammatory cytokines IL-10 and IL-1RA in monocytes/macrophages [PMID:10982546, PMID:11222466, PMID:15369797]. Bidirectional genetic models demonstrate that adiponectin deficiency causes diet-induced insulin resistance and shortened lifespan, while overexpression extends healthspan by reducing systemic inflammation and tissue fibrosis [PMID:12068289, PMID:33904399]."},"prefetch_data":{"uniprot":{"accession":"Q15848","full_name":"Adiponectin","aliases":["30 kDa adipocyte complement-related protein","Adipocyte complement-related 30 kDa protein","ACRP30","Adipocyte, C1q and collagen domain-containing protein","Adipose most abundant gene transcript 1 protein","apM-1","Gelatin-binding protein"],"length_aa":244,"mass_kda":26.4,"function":"Important adipokine involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic and anti-inflammatory activities. Stimulates AMPK phosphorylation and activation in the liver and the skeletal muscle, enhancing glucose utilization and fatty-acid combustion. Antagonizes TNF by negatively regulating its expression in various tissues such as liver and macrophages, and also by counteracting its effects. Inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. May play a role in cell growth, angiogenesis and tissue remodeling by binding and sequestering various growth factors with distinct binding affinities, depending on the type of complex, LMW, MMW or HMW","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q15848/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADIPOQ","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ADIPOQ","total_profiled":1310},"omim":[{"mim_id":"620225","title":"SUPPRESSOR OF GLUCOSE, AUTOPHAGY-ASSOCIATED PROTEIN 1; SOGA1","url":"https://www.omim.org/entry/620225"},{"mim_id":"620018","title":"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 4; PDIA4","url":"https://www.omim.org/entry/620018"},{"mim_id":"618647","title":"C1q- AND TNF-RELATED PROTEIN 2; C1QTNF2","url":"https://www.omim.org/entry/618647"},{"mim_id":"615603","title":"CALCINEURIN-LIKE PHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; CPPED1","url":"https://www.omim.org/entry/615603"},{"mim_id":"615229","title":"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 4; C1QL4","url":"https://www.omim.org/entry/615229"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":843.2},{"tissue":"breast","ntpm":252.6}],"url":"https://www.proteinatlas.org/search/ADIPOQ"},"hgnc":{"alias_symbol":["ACRP30","apM1","GBP28","adiponectin"],"prev_symbol":["ACDC"]},"alphafold":{"accession":"Q15848","domains":[{"cath_id":"2.60.120.40","chopping":"113-240","consensus_level":"high","plddt":95.8291,"start":113,"end":240}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15848","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15848-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15848-F1-predicted_aligned_error_v6.png","plddt_mean":79.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADIPOQ","jax_strain_url":"https://www.jax.org/strain/search?query=ADIPOQ"},"sequence":{"accession":"Q15848","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15848.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15848/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15848"}},"corpus_meta":[{"pmid":"11479628","id":"PMC_11479628","title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.","date":"2001","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11479628","citation_count":2034,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15897298","id":"PMC_15897298","title":"Adiponectin and adiponectin receptors.","date":"2005","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15897298","citation_count":1966,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8631877","id":"PMC_8631877","title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8631877","citation_count":1746,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12068289","id":"PMC_12068289","title":"Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.","date":"2002","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12068289","citation_count":1667,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11854024","id":"PMC_11854024","title":"ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.","date":"2002","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/11854024","citation_count":947,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12496257","id":"PMC_12496257","title":"Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12496257","citation_count":872,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11748271","id":"PMC_11748271","title":"Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.","date":"2001","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11748271","citation_count":718,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8947845","id":"PMC_8947845","title":"Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma.","date":"1996","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8947845","citation_count":698,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14624132","id":"PMC_14624132","title":"Obesity, adiponectin and vascular inflammatory disease.","date":"2003","source":"Current opinion in lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/14624132","citation_count":576,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29978896","id":"PMC_29978896","title":"Adiponectin Regulation and Function.","date":"2018","source":"Comprehensive Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29978896","citation_count":481,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23266767","id":"PMC_23266767","title":"Role of leptin and adiponectin in insulin resistance.","date":"2012","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23266767","citation_count":465,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14522956","id":"PMC_14522956","title":"Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14522956","citation_count":391,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15231994","id":"PMC_15231994","title":"A family of Acrp30/adiponectin structural and functional paralogs.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15231994","citation_count":357,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12087086","id":"PMC_12087086","title":"Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12087086","citation_count":307,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33088464","id":"PMC_33088464","title":"Adiponectin: Role in Physiology and Pathophysiology.","date":"2020","source":"International journal of preventive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33088464","citation_count":242,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18854421","id":"PMC_18854421","title":"APPL1: role in adiponectin signaling and beyond.","date":"2008","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18854421","citation_count":234,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19029992","id":"PMC_19029992","title":"Protective vascular and myocardial effects of adiponectin.","date":"2008","source":"Nature clinical practice. Cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19029992","citation_count":231,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12007537","id":"PMC_12007537","title":"ACRP30, a new hormone controlling fat and glucose metabolism.","date":"2002","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12007537","citation_count":203,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16570162","id":"PMC_16570162","title":"Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines.","date":"2006","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/16570162","citation_count":188,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19359049","id":"PMC_19359049","title":"Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies.","date":"2009","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/19359049","citation_count":176,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18069030","id":"PMC_18069030","title":"Adiponectin: an update.","date":"2008","source":"Diabetes & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18069030","citation_count":160,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11469400","id":"PMC_11469400","title":"Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes.","date":"2000","source":"International journal of experimental diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/11469400","citation_count":155,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11246823","id":"PMC_11246823","title":"Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes.","date":"2000","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/11246823","citation_count":150,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10444069","id":"PMC_10444069","title":"Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10444069","citation_count":147,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15705753","id":"PMC_15705753","title":"Expression of adiponectin and its receptors in swine.","date":"2005","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/15705753","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16443793","id":"PMC_16443793","title":"ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16443793","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14749263","id":"PMC_14749263","title":"Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/14749263","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24170312","id":"PMC_24170312","title":"Adiponectin and energy homeostasis.","date":"2014","source":"Reviews in endocrine & metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24170312","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24297186","id":"PMC_24297186","title":"Adiponectin signaling in the liver.","date":"2014","source":"Reviews in endocrine & metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24297186","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27629236","id":"PMC_27629236","title":"Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.","date":"2016","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27629236","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32188008","id":"PMC_32188008","title":"Adiponectin and Cognitive Decline.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32188008","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19141678","id":"PMC_19141678","title":"Niacin stimulates adiponectin secretion through the GPR109A receptor.","date":"2009","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19141678","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15544426","id":"PMC_15544426","title":"Adiponectin, an adipocyte-derived protein.","date":"2005","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/15544426","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18311774","id":"PMC_18311774","title":"Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.","date":"2008","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/18311774","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11444852","id":"PMC_11444852","title":"Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11444852","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28585210","id":"PMC_28585210","title":"Adiponectin-Resistance in Obesity.","date":"2017","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/28585210","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10095105","id":"PMC_10095105","title":"Organization of the gene for gelatin-binding protein (GBP28).","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10095105","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15616038","id":"PMC_15616038","title":"Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene.","date":"2005","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15616038","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14683455","id":"PMC_14683455","title":"Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine.","date":"2003","source":"Current drug targets. Immune, endocrine and metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/14683455","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30974901","id":"PMC_30974901","title":"Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30974901","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20536390","id":"PMC_20536390","title":"Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors.","date":"2010","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20536390","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33904399","id":"PMC_33904399","title":"Adiponectin preserves metabolic fitness during aging.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33904399","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25562427","id":"PMC_25562427","title":"Signaling pathway for adiponectin expression in adipocytes by osteocalcin.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25562427","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29414510","id":"PMC_29414510","title":"Adiponectin AS lncRNA inhibits adipogenesis by transferring from nucleus to cytoplasm and attenuating Adiponectin mRNA translation.","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/29414510","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19003726","id":"PMC_19003726","title":"Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels.","date":"2008","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/19003726","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28721260","id":"PMC_28721260","title":"Adiponectin/adiponectin receptor in disease and aging.","date":"2015","source":"NPJ aging and mechanisms of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28721260","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20875820","id":"PMC_20875820","title":"Adiponectin receptor binding proteins--recent advances in elucidating adiponectin signalling pathways.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20875820","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27965423","id":"PMC_27965423","title":"Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC.","date":"2016","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27965423","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15616040","id":"PMC_15616040","title":"Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians.","date":"2005","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15616040","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28473178","id":"PMC_28473178","title":"Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification.","date":"2017","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/28473178","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12728641","id":"PMC_12728641","title":"The genetics of adiponectin.","date":"2003","source":"Current diabetes reports","url":"https://pubmed.ncbi.nlm.nih.gov/12728641","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15504979","id":"PMC_15504979","title":"Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15504979","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29574056","id":"PMC_29574056","title":"Combining a Toggle Switch and a Repressilator within the AC-DC Circuit Generates Distinct Dynamical Behaviors.","date":"2018","source":"Cell systems","url":"https://pubmed.ncbi.nlm.nih.gov/29574056","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23432843","id":"PMC_23432843","title":"GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK.","date":"2013","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/23432843","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17448181","id":"PMC_17448181","title":"Migraine and adiponectin: is there a connection?","date":"2007","source":"Cephalalgia : an international journal of headache","url":"https://pubmed.ncbi.nlm.nih.gov/17448181","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35932043","id":"PMC_35932043","title":"Segmentation, tracking and cell cycle analysis of live-cell imaging data with Cell-ACDC.","date":"2022","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/35932043","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26257862","id":"PMC_26257862","title":"Involvement of adiponectin in the pathogenesis of dystrophinopathy.","date":"2015","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/26257862","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30791536","id":"PMC_30791536","title":"Pulmonary Hypertension and Obesity: Focus on Adiponectin.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30791536","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21397927","id":"PMC_21397927","title":"Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.","date":"2011","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/21397927","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37686525","id":"PMC_37686525","title":"Role of Leptin and Adiponectin in Carcinogenesis.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37686525","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27061803","id":"PMC_27061803","title":"Adiponectin and colorectal cancer.","date":"2016","source":"Surgery today","url":"https://pubmed.ncbi.nlm.nih.gov/27061803","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31456747","id":"PMC_31456747","title":"Potential Adiponectin Receptor Response Modifier Therapeutics.","date":"2019","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31456747","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24417948","id":"PMC_24417948","title":"Cardiometabolic effects of adiponectin.","date":"2013","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24417948","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22328772","id":"PMC_22328772","title":"Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection.","date":"2012","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22328772","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29115433","id":"PMC_29115433","title":"Adiponectin promotes preadipocyte differentiation via the PPARγ pathway.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/29115433","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19531600","id":"PMC_19531600","title":"Mutation of the membrane-associated M1 protease APM1 results in distinct embryonic and seedling developmental defects in Arabidopsis.","date":"2009","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/19531600","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16131485","id":"PMC_16131485","title":"The v-SNARE Vti1a regulates insulin-stimulated glucose transport and Acrp30 secretion in 3T3-L1 adipocytes.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16131485","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22327423","id":"PMC_22327423","title":"Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.","date":"2012","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22327423","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19008231","id":"PMC_19008231","title":"Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19008231","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22449616","id":"PMC_22449616","title":"Genetics of adiponectin.","date":"2012","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/22449616","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24740426","id":"PMC_24740426","title":"Association of adiponectin gene (ADIPOQ) rs2241766 polymorphism with obesity in adults: a meta-analysis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24740426","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23510830","id":"PMC_23510830","title":"Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages.","date":"2013","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/23510830","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17357881","id":"PMC_17357881","title":"Measurement of salivary adiponectin levels.","date":"2007","source":"Acta diabetologica","url":"https://pubmed.ncbi.nlm.nih.gov/17357881","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23017716","id":"PMC_23017716","title":"Glucocorticoid effects on adiponectin expression.","date":"2012","source":"Vitamins and hormones","url":"https://pubmed.ncbi.nlm.nih.gov/23017716","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24417947","id":"PMC_24417947","title":"Adiponectin effects on the kidney.","date":"2013","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24417947","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11244461","id":"PMC_11244461","title":"Characterization of mouse GBP28 and its induction by exposure to cold.","date":"2001","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/11244461","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20332107","id":"PMC_20332107","title":"Dimerization of adiponectin receptor 1 is inhibited by adiponectin.","date":"2010","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/20332107","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23658423","id":"PMC_23658423","title":"Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals.","date":"2013","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/23658423","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23401034","id":"PMC_23401034","title":"Adiponectin modulates NK-cell function.","date":"2013","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23401034","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21479819","id":"PMC_21479819","title":"Adiponectin and plant-derived mammalian adiponectin homolog exert a protective effect in murine colitis.","date":"2011","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21479819","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36428526","id":"PMC_36428526","title":"Targeting Adiponectin in Breast Cancer.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/36428526","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39106421","id":"PMC_39106421","title":"Adiponectin and Adiponectin Receptors in Atherosclerosis.","date":"2025","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/39106421","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23667684","id":"PMC_23667684","title":"Adiponectin increases secretion of rat submandibular gland via adiponectin receptors-mediated AMPK signaling.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23667684","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25223469","id":"PMC_25223469","title":"Association of ADIPOQ polymorphisms with obesity risk: a meta-analysis.","date":"2014","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25223469","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20627864","id":"PMC_20627864","title":"Metabolic acidosis lowers circulating adiponectin through inhibition of adiponectin gene transcription.","date":"2010","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/20627864","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22492282","id":"PMC_22492282","title":"Adiponectin, adiponectin receptors, and epigenetic regulation of adipogenesis.","date":"2012","source":"Cold Spring Harbor symposia on quantitative biology","url":"https://pubmed.ncbi.nlm.nih.gov/22492282","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34959666","id":"PMC_34959666","title":"An Explanation for the Adiponectin Paradox.","date":"2021","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34959666","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23990400","id":"PMC_23990400","title":"Assembly of adiponectin oligomers.","date":"2014","source":"Reviews in endocrine & metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/23990400","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19263799","id":"PMC_19263799","title":"Identification of a regulatory single nucleotide polymorphism in the adiponectin (APM1) gene associated with type 2 diabetes in Han nationality.","date":"2008","source":"Biomedical and environmental sciences : BES","url":"https://pubmed.ncbi.nlm.nih.gov/19263799","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26631404","id":"PMC_26631404","title":"Downregulation of adiponectin system in granulosa cells and low levels of HMW adiponectin in PCOS.","date":"2015","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26631404","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30241458","id":"PMC_30241458","title":"Asymmetric expression of H19 and ADIPOQ in concave/convex paravertebral muscles is associated with severe adolescent idiopathic scoliosis.","date":"2018","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/30241458","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20232346","id":"PMC_20232346","title":"Effect of adiponectin on apoptosis: proapoptosis or antiapoptosis?","date":"2010","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20232346","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39287861","id":"PMC_39287861","title":"Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction.","date":"2024","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/39287861","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22876919","id":"PMC_22876919","title":"Therapeutic perspectives for adiponectin: an update.","date":"2012","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22876919","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32065783","id":"PMC_32065783","title":"Adiponectin in renal fibrosis.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32065783","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17466005","id":"PMC_17466005","title":"Maternal serum adiponectin and infant birthweight: the role of adiponectin isoform distribution.","date":"2007","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17466005","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17270171","id":"PMC_17270171","title":"Effect of N-acetylcysteine on plasma adiponectin and renal adiponectin receptors in streptozotocin-induced diabetic rats.","date":"2006","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17270171","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35628118","id":"PMC_35628118","title":"Role of Leptin and Adiponectin in Endometrial Cancer.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35628118","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16516854","id":"PMC_16516854","title":"ACRP30 is secreted from 3T3-L1 adipocytes via a Rab11-dependent pathway.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16516854","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31388414","id":"PMC_31388414","title":"New software for automated cilia detection in cells (ACDC).","date":"2019","source":"Cilia","url":"https://pubmed.ncbi.nlm.nih.gov/31388414","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11479627","id":"PMC_11479627","title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.","date":"2001","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11479627","citation_count":3832,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12368907","id":"PMC_12368907","title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.","date":"2002","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12368907","citation_count":3297,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7592907","id":"PMC_7592907","title":"A novel serum protein similar to C1q, produced exclusively in adipocytes.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7592907","citation_count":2549,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12802337","id":"PMC_12802337","title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12802337","citation_count":2514,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10604883","id":"PMC_10604883","title":"Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.","date":"1999","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/10604883","citation_count":1753,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8619847","id":"PMC_8619847","title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8619847","citation_count":1642,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10982546","id":"PMC_10982546","title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway.","date":"2000","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/10982546","citation_count":1412,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11222466","id":"PMC_11222466","title":"Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages.","date":"2001","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/11222466","citation_count":1044,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10961870","id":"PMC_10961870","title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10961870","citation_count":1013,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14699128","id":"PMC_14699128","title":"Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14699128","citation_count":956,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14551151","id":"PMC_14551151","title":"Adiponectin and metabolic syndrome.","date":"2003","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14551151","citation_count":879,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28635626","id":"PMC_28635626","title":"Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28635626","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12944390","id":"PMC_12944390","title":"Adiponectin stimulates production of nitric oxide in vascular endothelial cells.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12944390","citation_count":833,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12878598","id":"PMC_12878598","title":"Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12878598","citation_count":821,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12611609","id":"PMC_12611609","title":"The role of the novel adipocyte-derived hormone adiponectin in human disease.","date":"2003","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12611609","citation_count":816,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15239085","id":"PMC_15239085","title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","date":"2004","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15239085","citation_count":782,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12829646","id":"PMC_12829646","title":"Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.","date":"2003","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12829646","citation_count":673,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15210937","id":"PMC_15210937","title":"T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15210937","citation_count":670,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14718574","id":"PMC_14718574","title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources.","date":"2004","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/14718574","citation_count":658,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14557259","id":"PMC_14557259","title":"Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14557259","citation_count":642,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15369797","id":"PMC_15369797","title":"Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15369797","citation_count":640,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12829629","id":"PMC_12829629","title":"Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors.","date":"2003","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12829629","citation_count":621,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15502375","id":"PMC_15502375","title":"Adiponectin as a biomarker of the metabolic syndrome.","date":"2004","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/15502375","citation_count":589,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14983034","id":"PMC_14983034","title":"Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14983034","citation_count":579,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11812766","id":"PMC_11812766","title":"Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.","date":"2002","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11812766","citation_count":574,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12736161","id":"PMC_12736161","title":"Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.","date":"2003","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12736161","citation_count":566,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47504,"output_tokens":4767,"usd":0.107009},"stage2":{"model":"claude-opus-4-6","input_tokens":8352,"output_tokens":3576,"usd":0.19674},"total_usd":0.692262,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":62084,"output_tokens":8034,"usd":0.153381},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":12216,"output_tokens":3827,"usd":0.235132}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"AdipoQ/adiponectin is a novel adipose-specific secreted protein with a collagenous domain (Gly-X-Y repeats) and a globular C1q-like domain; its expression is restricted to mature adipocytes and is significantly reduced in adipose tissue of obese mice and humans.\",\n      \"method\": \"mRNA differential display, cDNA cloning, Northern blot, tissue expression profiling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational cloning paper replicated across multiple labs; domain architecture confirmed independently\",\n      \"pmids\": [\"8631877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"GBP28 (adiponectin) is a gelatin-binding plasma protein that forms homo-trimers via its collagenous domain which further assemble into higher-order oligomeric complexes; the protein migrates as ~420 kDa on gel chromatography but 28 kDa (reducing) or 68 kDa (non-reducing) on SDS-PAGE.\",\n      \"method\": \"Gelatin-affinity chromatography, gel chromatography, SDS-PAGE, N-terminal sequencing, peptide mapping\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical purification and structural characterization\",\n      \"pmids\": [\"8947845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Insulin-stimulated secretion of ACRP30 from 3T3-L1 adipocytes requires phosphatidylinositol 3-kinase activity; ACRP30 resides in a regulated secretory compartment that is distinct from and non-overlapping with the GLUT4 compartment.\",\n      \"method\": \"PI3-kinase inhibitors (wortmannin/LY294002), deconvolution immunofluorescence microscopy, secretion assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — pharmacological dissection combined with high-resolution localization imaging in a defined cell model\",\n      \"pmids\": [\"10444069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Recombinant Acrp30 injection transiently abolishes hyperglycemia in ob/ob, NOD, and streptozotocin-treated mice without increasing insulin levels, and enhances the ability of sub-physiological insulin to suppress glucose production in isolated hepatocytes, identifying adipose tissue as a source of an insulin-sensitizing signal acting on the liver.\",\n      \"method\": \"Recombinant protein injection in multiple mouse models, isolated hepatocyte glucose output assay\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple disease models with in vivo and ex vivo orthogonal approaches, highly cited foundational study\",\n      \"pmids\": [\"11479628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Acrp30 acutely lowers hepatic glucose production by reducing expression of gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), and decreasing glucose flux through G6Pase, without affecting peripheral glucose uptake.\",\n      \"method\": \"Pancreatic euglycemic clamp in conscious mice, isotope tracer glucose flux analysis, hepatic enzyme mRNA quantification\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rigorous isotope clamp methodology with hepatic enzyme expression data\",\n      \"pmids\": [\"11748271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Adiponectin knockout mice exhibit delayed plasma free fatty acid clearance, low FATP-1 mRNA in muscle, elevated TNF-α in adipose tissue and plasma, and severe diet-induced insulin resistance with reduced IRS-1-associated PI3-kinase activity in muscle; viral re-expression of adiponectin reversed all these defects.\",\n      \"method\": \"Gene knockout mouse, viral-mediated re-expression, PI3-kinase activity assay, mRNA quantification, cultured myocyte experiments\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function KO with rescue, multiple molecular endpoints, highly cited\",\n      \"pmids\": [\"12068289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Acrp30 circulates as two major complexes: a lower-MW trimer-dimer and a high-MW (HMW) complex; oligomer formation critically depends on disulfide bond formation at Cys-39; mutation of Cys-39 produces trimers subject to proteolytic cleavage. Trimeric Acrp30 (C39S or DTT-reduced) is significantly more bioactive than HMW forms in reducing serum glucose and suppressing hepatic glucose output in primary hepatocytes.\",\n      \"method\": \"Recombinant protein expression, site-directed mutagenesis (C39S), DTT reduction, native gel electrophoresis, in vivo glucose assay, primary hepatocyte glucose output assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis + reconstitution + in vivo and ex vivo functional assays in a single study\",\n      \"pmids\": [\"12496257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Only hexameric and higher MW oligomers of Acrp30 activate NF-κB in C2C12 myocytes via phosphorylation and degradation of IκB-α; trimeric Acrp30 or the isolated globular domain (gAcrp30) cannot activate NF-κB, demonstrating oligomerization-state-dependent signaling specificity.\",\n      \"method\": \"Reporter gene assay (NF-κB-luciferase), immunoblot for IκB-α phosphorylation/degradation, purified oligomeric fractions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution with separated oligomers, orthogonal reporter and immunoblot readouts\",\n      \"pmids\": [\"12087086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Trimeric Acrp30 (but not hexameric or HMW forms) activates AMPK-α by phosphorylation at Thr172 in isolated rat muscle, while HMW/hexameric forms activate NF-κB but not AMPK; the two forms thus activate distinct signal transduction pathways, and HMW/hexamer assembly requires Cys22-mediated disulfide bonds.\",\n      \"method\": \"Freeze-etch electron microscopy, dithiothreitol reduction, C22A mutagenesis, AMPK kinase assay on isolated rat extensor digitorum longus, NF-κB reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural EM, mutagenesis, and independent biochemical assays in same study\",\n      \"pmids\": [\"14522956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Niacin stimulates adiponectin secretion through the GPR109A receptor via a pertussis-toxin-sensitive (Gi) pathway; GPR109A knockout mice show no increase in serum adiponectin after niacin, demonstrating receptor-dependent regulation of adiponectin secretion.\",\n      \"method\": \"Primary adipocyte secretion assay, GPR109A knockout mouse, pertussis toxin pre-treatment, serum adiponectin measurement\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition plus genetic KO with in vivo and in vitro concordant results\",\n      \"pmids\": [\"19141678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ACRP30 secretion from 3T3-L1 adipocytes proceeds via a Rab11-dependent recycling endosome pathway; dominant-negative Rab11-S25N expression reduces basal and insulin-stimulated ACRP30 secretion, and Arf6 also contributes to this trafficking route.\",\n      \"method\": \"Dominant-negative Rab11-S25N overexpression, endosome ablation, Brefeldin A treatment, secretion assay, co-localization with transferrin receptor\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative approach plus pharmacological inhibition with secretion readout, single lab\",\n      \"pmids\": [\"16516854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The v-SNARE Vti1a is identified in GLUT4-containing membranes of adipocytes; siRNA-mediated depletion of Vti1a significantly inhibits both adiponectin secretion and insulin-stimulated glucose uptake, indicating Vti1a regulates a step shared by ACRP30 and GLUT4 trafficking.\",\n      \"method\": \"Proteomics/mass spectrometry on purified GLUT4 vesicles, siRNA knockdown, adiponectin secretion assay, deoxyglucose uptake assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — proteomics discovery plus siRNA loss-of-function with two orthogonal functional readouts\",\n      \"pmids\": [\"16131485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APPL1 interacts directly with the intracellular region of AdipoR1 and AdipoR2 via its phosphotyrosine-binding (PTB) domain and mediates adiponectin signaling and adiponectin-dependent insulin sensitization in skeletal muscle; APPL2 competitively inhibits APPL1 to block adiponectin signaling.\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping, dominant-negative/overexpression studies in muscle cells, glucose uptake assay\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with domain mapping plus functional signaling readouts, replicated across labs\",\n      \"pmids\": [\"18854421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AdipoR1 forms homodimers via a GxxxG motif in its fifth transmembrane domain; adiponectin decreases AdipoR1 dimerization in a concentration-dependent manner, primarily through its collagen-like domain, representing the first direct readout of adiponectin binding at AdipoR1.\",\n      \"method\": \"Bimolecular fluorescence complementation (BiFC), flow cytometry, GxxxG-to-Phe/Glu mutagenesis, endogenous dimer detection in cell lines and human muscle tissue\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-function mutagenesis combined with BiFC and orthogonal co-immunoprecipitation\",\n      \"pmids\": [\"20332107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Caveolin-3 (Cav-3) co-localizes with AdipoR1 and forms an AdipoR1/Cav-3 complex via Cav-3 scaffolding domain binding motifs; this interaction is required for adiponectin-initiated AMPK-dependent and AMPK-independent (adenylate cyclase/PKA) cardioprotective signaling; APPL1 and adenylate cyclase form a protein complex with AdipoR1 in a Cav-3-dependent manner.\",\n      \"method\": \"Cav-3 knockout mice, co-immunoprecipitation, myocardial ischemia-reperfusion injury model, infarct size/apoptosis/cardiac function measurements, AMPK and PKA activity assays\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with molecular Co-IP and multiple functional cardiac endpoints\",\n      \"pmids\": [\"22328772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Osteocalcin (GluOC) induces adiponectin expression in adipocytes via GPRC6A → cAMP → PKA → Src → Rap1 → ERK → CREB → PPARγ signaling cascade; this pathway was confirmed in 3T3-L1 adipocytes using specific inhibitors and in vivo by oral GluOC administration in mice.\",\n      \"method\": \"Signaling pathway inhibitors (U0126 for ERK, PKA inhibitors), phosphorylation assays, PPARγ and CREB reporter assays, in vivo mouse model\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological inhibitors tracing a signaling cascade with in vivo confirmation, single lab\",\n      \"pmids\": [\"25562427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In mdx (dystrophin-deficient) mice, adiponectin replenishment reduces muscle inflammation and oxidative stress, upregulates utrophin A expression, and improves muscle force via AdipoR1-mediated AMPK-SIRT1-PGC-1α signaling leading to downregulation of NF-κB.\",\n      \"method\": \"Adiponectin transgenic x mdx cross, AMPK/SIRT1/PGC-1α pathway western blots, in vivo grip strength/endurance tests, Evans Blue Dye muscle damage assay, human myotube primary cultures\",\n      \"journal\": \"Skeletal muscle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with multiple molecular pathway endpoints replicated in human cell model\",\n      \"pmids\": [\"26257862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"An AdipoQ antisense (AS) lncRNA transfers from nucleus to cytoplasm during adipogenic differentiation and forms an RNA duplex with AdipoQ mRNA to suppress its translation, thereby inhibiting adipogenesis; adenoviral delivery of AdipoQ AS lncRNA reduces adipose tissue and liver triglycerides in HFD mice.\",\n      \"method\": \"RNA half-life assay, RNA duplex detection, nuclear-cytoplasmic fractionation, adenoviral overexpression in vivo, HFD mouse model\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA duplex formation plus in vivo loss/gain-of-function, single lab\",\n      \"pmids\": [\"29414510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Adiponectin oligomers assemble via a 'cystine ratchet' mechanism involving sequential disulfide bond formation; post-translational modifications (hydroxylation and glycosylation of collagen-domain lysines) affect higher-order oligomer assembly and secretion.\",\n      \"method\": \"In vitro oligomer assembly reactions, mass spectrometry, SDS-PAGE under reducing/non-reducing conditions\",\n      \"journal\": \"Reviews in endocrine & metabolic disorders\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical reconstitution with mass spectrometry; review incorporating original data, single lab model\",\n      \"pmids\": [\"23990400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Adiponectin null mice display accelerated age-related glucose and lipid metabolism disorders and shortened lifespan on both chow and high-fat diet; transgenic mice with elevated circulating adiponectin have improved systemic insulin sensitivity, reduced tissue inflammation and fibrosis, and prolonged median lifespan.\",\n      \"method\": \"Adiponectin knockout mouse, adiponectin transgenic overexpression mouse, metabolic phenotyping, tissue inflammation/fibrosis histology, lifespan analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementary KO and transgenic gain-of-function genetic models with multiple physiological endpoints\",\n      \"pmids\": [\"33904399\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Adiponectin (ADIPOQ/Acrp30) is an adipocyte-secreted collagen-domain protein that circulates as oligomers (trimers, hexamers, HMW forms) whose assembly depends on Cys-mediated disulfide bonds and lysine post-translational modifications; trimers preferentially activate AMPK (via AdipoR1/R2 → APPL1 adaptor) to suppress hepatic gluconeogenesis and stimulate muscle fatty acid oxidation, while HMW/hexameric forms activate NF-κB, with AdipoR1 dimerization modulated by adiponectin binding; secretion is regulated by insulin via a PI3K-dependent, Rab11/Arf6-recycling endosome pathway, and downstream cardioprotective signaling requires assembly of an AdipoR1/Cav-3/APPL1/adenylate cyclase complex.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Acrp30 (ADIPOQ) is a novel 30-kDa secretory protein made exclusively in adipocytes, forming large homo-oligomers that undergo post-translational modifications; its secretion is enhanced by insulin, identifying it as an abundant serum protein with structural similarity to complement factor C1q.\",\n      \"method\": \"Differential display cloning, Western blot, oligomer characterization, insulin stimulation assay in adipocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — original discovery with multiple orthogonal methods, highly cited foundational paper\",\n      \"pmids\": [\"7592907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"AdipoQ encodes a 247-amino-acid secreted protein with a signal sequence, collagenous (Gly-X-Y) region, and a C1q-like globular domain; expression is adipose-specific and restricted to mature adipocytes, and is significantly reduced in obese mice and humans.\",\n      \"method\": \"mRNA differential display, cDNA cloning, Northern blot, in situ hybridization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original cloning with multiple expression methods, highly cited foundational paper\",\n      \"pmids\": [\"8631877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"GBP28 (ADIPOQ) is a gelatin-binding plasma protein purified from human plasma; on SDS-PAGE it migrates as 28 kDa (reducing) or 68 kDa (non-reducing), and by gel chromatography as ~420 kDa, indicating disulfide-linked oligomeric complexes.\",\n      \"method\": \"Affinity chromatography (gelatin-Cellulofine), gel filtration, SDS-PAGE, N-terminal sequencing\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical purification and characterization of protein from human plasma\",\n      \"pmids\": [\"8947845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ADIPOQ (adiponectin) in 3T3-L1 adipocytes is stored in a regulated secretory compartment distinct from GLUT4 vesicles; insulin-stimulated secretion of ACRP30 requires phosphatidylinositol-3-kinase activity, and ACRP30 and GLUT4 occupy non-overlapping intracellular compartments.\",\n      \"method\": \"Deconvolution immunofluorescence microscopy, PI3K inhibitor (wortmannin/LY294002) treatment, insulin stimulation, secretion assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct imaging and pharmacological dissection in adipocytes\",\n      \"pmids\": [\"10444069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Adiponectin inhibits TNF-α-induced expression of endothelial adhesion molecules (VCAM-1, E-selectin, ICAM-1) and monocyte adhesion to human aortic endothelial cells at physiological concentrations.\",\n      \"method\": \"Cell ELISA, adhesion assay with THP-1 cells, treatment of HAECs with recombinant adiponectin\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro functional assay with primary endothelial cells, highly cited\",\n      \"pmids\": [\"10604883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Adiponectin inhibits TNF-α-induced NF-κB activation in endothelial cells by suppressing IκB-α phosphorylation through a cAMP/PKA-dependent pathway; it specifically binds HAECs in a saturable manner without affecting TNF-α receptor interaction.\",\n      \"method\": \"Cell ELISA with biotinylated adiponectin, EMSA (NF-κB binding), immunoblotting (IκB-α phosphorylation), adenylate cyclase and PKA inhibitors, cAMP measurement\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal mechanistic methods, highly cited\",\n      \"pmids\": [\"10982546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Adiponectin suppresses macrophage-to-foam cell transformation by reducing class A scavenger receptor (MSR) expression at mRNA and protein levels via decreased MSR promoter activity, without affecting CD36 expression; it also inhibits macrophage phagocytosis via the complement receptor C1qRp.\",\n      \"method\": \"Cholesteryl ester assay, Oil Red O staining, Northern blot, immunoblot, luciferase reporter assay, flow cytometry, anti-C1qRp antibody blockade\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including reporter assay and receptor blockade\",\n      \"pmids\": [\"11222466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Adiponectin suppresses growth of myelomonocytic progenitors and induces apoptosis (subdiploid peaks, oligonucleosomal DNA fragmentation) in acute myelomonocytic leukemia lines; it also suppresses macrophage phagocytosis and LPS-induced TNF-α production, partly via the C1q receptor C1qRp.\",\n      \"method\": \"Colony formation assay, flow cytometry (sub-G1), DNA fragmentation assay, anti-C1qRp antibody blockade, TNF-α ELISA\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays with defined receptor blockade\",\n      \"pmids\": [\"10961870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A single injection of recombinant Acrp30 in mice causes a 2–3-fold elevation in circulating levels and transiently lowers basal glucose; in isolated hepatocytes, Acrp30 enhances sub-physiological insulin-mediated suppression of glucose production, identifying the liver as a primary target organ.\",\n      \"method\": \"Recombinant protein injection in mice (ob/ob, NOD, STZ-treated), isolated hepatocyte glucose production assay\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and ex vivo mechanistic assays, highly cited\",\n      \"pmids\": [\"11479628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Adiponectin reverses insulin resistance in both obese and lipoatrophic mouse models by decreasing triglyceride content in muscle and liver through increased expression of fatty-acid combustion and energy dissipation molecules; combination of adiponectin and leptin fully reverses lipoatrophic insulin resistance.\",\n      \"method\": \"Recombinant adiponectin administration, triglyceride content assay in muscle/liver, gene expression profiling, adiponectin+leptin co-treatment in lipoatrophic mice\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vivo models with defined molecular readouts, 3832 citations\",\n      \"pmids\": [\"11479627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Intraperitoneal Acrp30 infusion during a euglycemic clamp reduces hepatic glucose production by 65% and decreases expression of gluconeogenic enzymes PEPCK and G6Pase by >50%, without affecting peripheral glucose uptake or glycolysis.\",\n      \"method\": \"Pancreatic euglycemic clamp in conscious mice, glucose flux measurement, hepatic mRNA analysis (PEPCK, G6Pase)\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rigorous in vivo clamp study with molecular readouts\",\n      \"pmids\": [\"11748271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Adiponectin activates AMP-activated protein kinase (AMPK) in skeletal muscle (both globular and full-length forms) and liver (full-length only), leading to phosphorylation of ACC, increased fatty-acid oxidation and glucose uptake; dominant-negative AMPK blocks all these effects.\",\n      \"method\": \"AMPK phosphorylation assay, ACC phosphorylation, fatty-acid oxidation assay, glucose uptake assay, dominant-negative AMPK mutant transfection in myocytes and hepatocytes\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — loss-of-function genetic epistasis with dominant-negative, multiple orthogonal assays, 3297 citations\",\n      \"pmids\": [\"12368907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Adiponectin-knockout mice show severe diet-induced insulin resistance with reduced IRS-1-associated PI3-kinase activity in muscle, elevated TNF-α in adipose tissue, delayed FFA clearance, and reduced muscle FATP-1 mRNA; viral re-expression of adiponectin reverses these defects.\",\n      \"method\": \"Gene knockout, PI3K activity assay, TNF-α mRNA measurement, FATP-1 mRNA, FFA clearance, viral rescue experiment in KO mice\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with rescue experiment and defined molecular pathway readouts\",\n      \"pmids\": [\"12068289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Acrp30 oligomer formation critically depends on disulfide bond formation via Cys-39; mutation of Cys-39 results in trimers that are more bioactive than higher-order oligomers with respect to lowering serum glucose and reducing hepatocyte glucose output; females display higher HMW complex levels than males.\",\n      \"method\": \"Mutagenesis (Cys-39 to Ser), DTT reduction, in vivo glucose measurement, primary hepatocyte glucose output assay, non-denaturing SDS-PAGE\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-function mutagenesis with in vivo and ex vivo bioactivity validation\",\n      \"pmids\": [\"12496257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Only hexameric and higher-MW forms of Acrp30 activate NF-κB (via IκB-α phosphorylation/degradation) in C2C12 myocytes; trimeric Acrp30 does not activate NF-κB, demonstrating oligomerization state-dependent signaling specificity.\",\n      \"method\": \"NF-κB reporter assay, IκB-α phosphorylation by immunoblot, purified trimers and hexamers from E. coli and 293T cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined oligomeric fractions tested in parallel with NF-κB reporter\",\n      \"pmids\": [\"12087086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Cloning of AdipoR1 (abundant in skeletal muscle) and AdipoR2 (predominant in liver) by expression cloning; both receptors have seven transmembrane domains but are structurally and functionally distinct from GPCRs; they mediate globular and full-length adiponectin binding and downstream AMPK and PPARα activation, fatty-acid oxidation, and glucose uptake.\",\n      \"method\": \"Expression cloning from C2C12 cDNA library, siRNA knockdown, AMPK/PPARα activity assays, fatty-acid oxidation, glucose uptake\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — expression cloning with siRNA loss-of-function and multiple functional readouts, 2514 citations\",\n      \"pmids\": [\"12802337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Trimeric and HMW/hexameric Acrp30 activate distinct signal transduction pathways: trimers activate AMPK (Thr172 phosphorylation) in muscle; HMW and hexamers activate NF-κB in C2C12 cells; Cys-22 disulfide bonds are required for hexamer and HMW assembly but not trimer stability.\",\n      \"method\": \"Freeze-etch electron microscopy, DTT reduction, Cys22Ala mutagenesis, AMPK phosphorylation assay (rat EDL muscle), NF-κB reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural EM plus mutagenesis plus multiple functional assays\",\n      \"pmids\": [\"14522956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The ratio of HMW to LMW adiponectin (S_A index), not absolute total adiponectin, correlates with insulin sensitivity; HMW adiponectin complex is the active form in vivo (dose-dependently lowers serum glucose), primarily acting on hepatic insulin sensitivity.\",\n      \"method\": \"Non-denaturing SDS-PAGE oligomer separation, euglycemic clamp, in vivo glucose infusion with defined oligomeric fractions in db/db mice and human cohorts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo dose-response with defined oligomeric fractions plus human clinical validation\",\n      \"pmids\": [\"14699128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Adiponectin stimulates NO production in vascular endothelial cells via a PI3K-dependent pathway involving phosphorylation of Akt (Ser473) and eNOS (Ser1179) by AMPK; dominant-negative AMPK (but not dominant-negative Akt) inhibits adiponectin-induced eNOS phosphorylation and NO production.\",\n      \"method\": \"DAF-2 DA fluorescent NO assay, phospho-specific immunoblotting, wortmannin inhibition, dominant-negative AMPK and Akt transfection in bovine aortic endothelial cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — loss-of-function genetic epistasis with multiple orthogonal methods\",\n      \"pmids\": [\"12944390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Adiponectin mutations G84R and G90S (associated with diabetes) fail to form HMW multimers; R112C and I164T mutants fail to assemble into trimers and show impaired secretion; an N-terminal Cys-to-Ser mutation abolishing multimers >trimers abrogates AMPK pathway activation in hepatocytes.\",\n      \"method\": \"Non-reducing/non-heat-denaturing SDS-PAGE, site-directed mutagenesis, transfection in NIH-3T3 cells, AMPK pathway assay in hepatocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-function mutagenesis correlated with functional AMPK assay\",\n      \"pmids\": [\"12878598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Adiponectin stimulates angiogenesis in vitro (HUVEC capillary differentiation and migration) and in vivo (Matrigel plug and corneal models) via cross-talk between AMPK and Akt signaling, both required for eNOS phosphorylation; dominant-negative AMPK blocks adiponectin-induced Akt phosphorylation, placing AMPK upstream of Akt.\",\n      \"method\": \"HUVEC tube formation, migration assay, dominant-negative AMPK and Akt transfection, phospho-immunoblotting, in vivo Matrigel and corneal angiogenesis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vitro confirmed by in vivo models\",\n      \"pmids\": [\"14557259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PPARγ/RXR heterodimer directly binds a functional PPAR-responsive element (PPRE) in the human adiponectin promoter to drive transcription; LRH-1 binds a separate responsive element and augments PPARγ-induced transactivation; point mutations in either element markedly reduce basal and TZD-induced adiponectin promoter activity.\",\n      \"method\": \"Promoter deletion/mutation analysis, luciferase reporter assay, EMSA (direct binding), TZD treatment of 3T3-L1 and rat adipocytes\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct DNA-binding demonstrated by EMSA plus mutagenesis in multiple cell systems\",\n      \"pmids\": [\"12829629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Adiponectin induces anti-inflammatory cytokines IL-10 and IL-1RA and suppresses IFN-γ production in primary human monocytes, macrophages, and dendritic cells; adiponectin-treated macrophages show reduced phagocytotic and allo-stimulatory capacity.\",\n      \"method\": \"Primary human monocyte/macrophage/DC culture, cytokine ELISA, phagocytosis assay, mixed lymphocyte reaction\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple primary cell types with functional readouts\",\n      \"pmids\": [\"15369797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"T-cadherin (a GPI-anchored extracellular protein expressed on endothelial and smooth muscle cells) acts as a receptor specifically for hexameric and HMW forms of adiponectin (not trimer or globular forms); binding requires eukaryotic post-translational modifications of adiponectin and the N-terminal cysteine required for hexamer/HMW formation.\",\n      \"method\": \"Retroviral cDNA expression library screening on adiponectin-coated magnetic beads in Ba/F3 cells, co-immunoprecipitation, binding assays with oligomeric fractions, Cys-mutant adiponectin\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — expression cloning plus co-IP with defined mutants\",\n      \"pmids\": [\"15210937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Adiponectin induces endothelial cell apoptosis (caspase-8, -9, -3 cascade activation) as a mechanism of anti-angiogenesis; in a mouse tumor model, adiponectin inhibits primary tumor growth by reducing neovascularization and increasing tumor cell apoptosis.\",\n      \"method\": \"Endothelial cell proliferation/migration assay, chick CAM assay, mouse corneal angiogenesis, caspase activation assays, mouse tumor model with neovascularization quantification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined caspase cascade in vitro confirmed in vivo tumor model\",\n      \"pmids\": [\"14983034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The v-SNARE Vti1a is a component of insulin-sensitive GLUT4-containing vesicles in adipocytes; siRNA-mediated depletion of Vti1a significantly inhibits both adiponectin (ACRP30) secretion and insulin-stimulated glucose uptake, indicating Vti1a regulates a step common to GLUT4 and ACRP30 trafficking.\",\n      \"method\": \"Proteomics (mass spectrometry) of purified GLUT4 membranes, siRNA knockdown, adiponectin secretion assay, deoxyglucose uptake assay in 3T3-L1 adipocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA loss-of-function with two orthogonal functional readouts\",\n      \"pmids\": [\"16131485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ACRP30 secretion from 3T3-L1 adipocytes is routed through Rab11-positive recycling endosomes; dominant-negative Rab11-S25N and endosome ablation reduce basal and insulin-stimulated ACRP30 secretion; Arf6 also contributes to this secretory pathway.\",\n      \"method\": \"Dominant-negative Rab11 overexpression, endosome ablation, Brefeldin A treatment, co-localization with transferrin receptor (endosomal marker), secretion assay in 3T3-L1 adipocytes\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative approach with functional secretion readout, single lab\",\n      \"pmids\": [\"16516854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APPL1, an adaptor protein with PTB domain, directly interacts with the intracellular regions of AdipoR1 and AdipoR2 and mediates adiponectin signaling, including AMPK activation and insulin sensitization in skeletal muscle; APPL1 is also required for adiponectin's anti-inflammatory and cytoprotective effects in endothelial cells.\",\n      \"method\": \"Co-immunoprecipitation, PTB domain binding assay, AMPK activity assay, glucose uptake in skeletal muscle, endothelial cell survival assay with APPL1 knockdown/overexpression\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein-protein interaction with loss-of-function functional readouts, independently replicated\",\n      \"pmids\": [\"18854421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Niacin stimulates adiponectin secretion through the GPR109A receptor via a pertussis toxin-sensitive (Gi) pathway; GPR109A knockout mice fail to increase adiponectin in response to niacin, and the effect is mimicked by β-hydroxybutyrate (endogenous GPR109A ligand) in primary adipocytes.\",\n      \"method\": \"In vivo niacin administration in rats and GPR109A-KO mice, primary adipocyte stimulation with pertussis toxin pretreatment, adiponectin ELISA, 3T3-L1 cell controls (low GPR109A expression)\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout mouse model plus pharmacological Gi inhibition, validated in multiple systems\",\n      \"pmids\": [\"19141678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AdipoR1 forms homodimers via a GxxxG motif in the fifth transmembrane domain; mutation of both glycines (to Phe or Glu) modulates dimerization; adiponectin decreases AdipoR1 dimerization in a concentration-dependent manner, primarily through its collagen-like domain.\",\n      \"method\": \"Bimolecular fluorescence complementation (BiFC), flow cytometry, GxxxG mutagenesis, endogenous AdipoR1 dimer detection in cell lines and human muscle tissue\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct visualization of dimerization with mutagenesis and ligand dose-response\",\n      \"pmids\": [\"20332107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Caveolin-3 is required for AdipoR1/Cav-3 complex formation via Cav-3 scaffolding domain motifs; AdipoR1/Cav-3 interaction is necessary for adiponectin-initiated AMPK-dependent and AMPK-independent (adenylate cyclase/PKA) cardioprotective signaling; APPL1 and adenylate cyclase form a complex with AdipoR1 in a Cav-3-dependent fashion.\",\n      \"method\": \"Co-immunoprecipitation, Cav-3 knockout mice (ischemia/reperfusion injury), infarct size measurement, AMPK activity assay, PKA inhibitor studies\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse model with co-IP and defined signaling cascade dissection\",\n      \"pmids\": [\"22328772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Osteocalcin (GluOC) induces adiponectin expression in adipocytes via GPRC6A receptor → cAMP → PKA → Src → Rap1 → ERK → CREB → PPARγ → adiponectin; U0126 (ERK inhibitor) and GPRC6A blockade attenuate CREB phosphorylation and adiponectin induction.\",\n      \"method\": \"Intracellular cAMP measurement, PKA activity, phospho-ERK/CREB immunoblot, U0126 inhibition, PPARγ luciferase reporter, intermittent GluOC oral administration in mice\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multi-step pathway validated with inhibitors and in vivo confirmation\",\n      \"pmids\": [\"25562427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Adiponectin protects mdx (Duchenne muscular dystrophy) mice via AdipoR1 and the AMPK-SIRT1-PGC-1α pathway, reducing NF-κB activation and inflammatory genes while upregulating utrophin A; adiponectin null mice have markedly reduced circulating adiponectin in the dystrophic context.\",\n      \"method\": \"mdx × adiponectin-transgenic cross, in vivo force measurement, Evans Blue Dye muscle damage assay, AMPK/SIRT1/PGC-1α immunoblot, NF-κB reporter, human myotube culture\",\n      \"journal\": \"Skeletal muscle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic mouse model with defined molecular pathway and functional phenotype\",\n      \"pmids\": [\"26257862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Adiponectin null mice display exacerbated age-related glucose and lipid metabolism disorders and significantly shortened lifespan; transgenic mice with elevated circulating adiponectin show improved systemic insulin sensitivity, reduced age-related tissue inflammation and fibrosis, and prolonged healthspan and median lifespan.\",\n      \"method\": \"Adiponectin knockout and transgenic overexpression mouse models, glucose/lipid tolerance tests, tissue fibrosis quantification, lifespan analysis on chow and HFD\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional genetic models (KO and overexpression) with defined metabolic and lifespan phenotypes\",\n      \"pmids\": [\"33904399\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADIPOQ (adiponectin/Acrp30) is an adipocyte-specific secreted hormone that circulates as trimers, hexamers, and high-molecular-weight (HMW) oligomers assembled via N-terminal disulfide bonds; HMW oligomers exert primary metabolic activity and bind T-cadherin and AdipoR1/R2, while trimers preferentially activate AMPK in muscle; upon binding AdipoR1 (muscle) or AdipoR2 (liver), adiponectin activates AMPK (phosphorylating ACC), increases fatty-acid oxidation and glucose uptake, suppresses hepatic gluconeogenesis (PEPCK, G6Pase), stimulates eNOS-mediated NO production via AMPK→Akt, inhibits NF-κB via cAMP/PKA, reduces macrophage scavenger receptor expression, and induces IL-10/IL-1RA; intracellular signaling is further regulated by the adaptor APPL1 (which binds AdipoR1/2 cytoplasmic domains) and by caveolin-3 scaffolding; adiponectin secretion from adipocytes is insulin-stimulated and routed through PI3K-dependent, Rab11/Arf6-regulated recycling endosomes, and is transcriptionally driven by PPARγ/RXR binding a functional PPRE in the ADIPOQ promoter.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"Adiponectin (ADIPOQ) is an adipocyte-secreted hormone that functions as a systemic insulin-sensitizing, anti-inflammatory, and metabolic-protective signal. The protein assembles via its collagenous domain into trimers, hexamers, and high-molecular-weight (HMW) oligomers through a cystine-ratchet mechanism involving Cys-39-mediated disulfide bonds and lysine hydroxylation/glycosylation; trimeric forms preferentially activate AMPK (Thr172 phosphorylation) via AdipoR1/APPL1 to suppress hepatic gluconeogenesis (downregulating PEPCK and G6Pase), while hexameric/HMW forms selectively activate NF-κB through IκBα degradation [PMID:12496257, PMID:14522956, PMID:12087086]. Insulin stimulates adiponectin secretion through a PI3K-dependent, Rab11/Arf6-recycling endosome pathway from a regulated compartment distinct from GLUT4 vesicles [PMID:10444069, PMID:16516854]. Adiponectin-null mice exhibit diet-induced insulin resistance, elevated TNF-α, impaired fatty acid clearance, and shortened lifespan, while adiponectin repletion reverses these defects and extends lifespan, establishing ADIPOQ as a central mediator of metabolic homeostasis and healthspan [PMID:12068289, PMID:33904399].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of ADIPOQ as an adipose-restricted secreted protein with collagen and C1q-like domains that forms higher-order oligomeric complexes established the structural framework for understanding its extracellular signaling biology.\",\n      \"evidence\": \"mRNA differential display cloning, gelatin-affinity purification, gel chromatography, and SDS-PAGE under reducing/non-reducing conditions in adipocyte cell lines and plasma\",\n      \"pmids\": [\"8631877\", \"8947845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor identity unknown\", \"Functional significance of oligomerization states unknown\", \"Post-translational modifications not characterized\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that insulin-stimulated adiponectin secretion requires PI3K and occurs from a compartment distinct from GLUT4 vesicles revealed that adiponectin release is an independently regulated secretory event.\",\n      \"evidence\": \"PI3K inhibitors (wortmannin/LY294002) and deconvolution immunofluorescence in 3T3-L1 adipocytes\",\n      \"pmids\": [\"10444069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of trafficking machinery (SNAREs, Rabs) not yet defined\", \"Signal connecting insulin receptor to secretory compartment not mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"In vivo administration of recombinant adiponectin suppressed hepatic glucose production by downregulating PEPCK and G6Pase across multiple diabetic mouse models, establishing adiponectin as a liver-targeted insulin-sensitizing hormone.\",\n      \"evidence\": \"Recombinant Acrp30 injection in ob/ob, NOD, and streptozotocin mice; pancreatic euglycemic clamp with isotope tracer glucose flux; hepatic enzyme mRNA quantification\",\n      \"pmids\": [\"11479628\", \"11748271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating hepatic action unknown\", \"Downstream kinase cascade not identified\", \"Which oligomeric form is bioactive in vivo unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Knockout and structure-function studies together revealed that adiponectin is essential for insulin sensitivity and fatty acid metabolism in vivo, and that oligomeric state dictates signaling specificity: trimers activate AMPK and suppress glucose output, while hexamers/HMW forms activate NF-κB.\",\n      \"evidence\": \"Adiponectin KO mice with viral rescue; C39S mutagenesis and DTT reduction producing defined oligomers; AMPK kinase assay on isolated muscle; NF-κB reporter and IκBα immunoblot in C2C12 myocytes\",\n      \"pmids\": [\"12068289\", \"12496257\", \"12087086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How oligomer-specific receptor engagement occurs is unknown\", \"Intracellular adaptor linking receptor to AMPK not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Freeze-etch EM and Cys22 mutagenesis defined the structural basis of HMW assembly and confirmed that trimeric, not HMW, adiponectin is the AMPK-activating species, solidifying oligomer-dependent signaling dichotomy.\",\n      \"evidence\": \"Freeze-etch electron microscopy of purified oligomers, C22A mutagenesis, AMPK Thr172 phosphorylation assay in rat muscle\",\n      \"pmids\": [\"14522956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full atomic structure of each oligomeric form not resolved\", \"In vivo relevance of trimer vs HMW ratio not established\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of Rab11-dependent recycling endosome trafficking and Vti1a SNARE involvement defined the intracellular secretory route for adiponectin and revealed partial mechanistic overlap with GLUT4 vesicle exocytosis.\",\n      \"evidence\": \"Dominant-negative Rab11-S25N, Arf6, and siRNA-mediated Vti1a depletion in 3T3-L1 adipocytes with secretion and glucose uptake assays; GLUT4 vesicle proteomics\",\n      \"pmids\": [\"16516854\", \"16131485\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full SNARE complex for adiponectin vesicles not reconstituted\", \"Whether Rab11 pathway is the sole secretory route is unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that APPL1 binds AdipoR1/R2 via its PTB domain and is competitively inhibited by APPL2 identified the first intracellular adaptor transducing adiponectin receptor activation to downstream kinases.\",\n      \"evidence\": \"Co-immunoprecipitation with domain mapping, dominant-negative and overexpression in muscle cells, glucose uptake assays\",\n      \"pmids\": [\"18854421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How APPL1 links to AMPK phosphorylation not resolved\", \"APPL2 regulation mechanism unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that AdipoR1 homodimerizes via a transmembrane GxxxG motif and that adiponectin binding disrupts this dimer provided the first direct biophysical readout of ligand–receptor engagement.\",\n      \"evidence\": \"Bimolecular fluorescence complementation, GxxxG mutagenesis, endogenous dimer detection in cell lines and human muscle\",\n      \"pmids\": [\"20332107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether dimer disruption is required for signaling not causally tested\", \"Crystal structure of receptor dimer-to-monomer transition lacking\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Assembly of an AdipoR1/Cav-3/APPL1/adenylate cyclase signaling complex was shown to be required for both AMPK-dependent and PKA-dependent cardioprotective signaling, extending adiponectin's mechanism into cardiac ischemia-reperfusion protection.\",\n      \"evidence\": \"Cav-3 knockout mice, co-immunoprecipitation, myocardial ischemia-reperfusion model with infarct size, apoptosis, and AMPK/PKA activity measurements\",\n      \"pmids\": [\"22328772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this complex exists in non-cardiac tissues not tested\", \"Stoichiometry and assembly dynamics of the complex unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Biochemical reconstitution of adiponectin oligomer assembly via sequential disulfide formation ('cystine ratchet') and characterization of collagen-domain lysine modifications explained how post-translational modifications control the ratio of secreted oligomeric species.\",\n      \"evidence\": \"In vitro oligomer assembly reactions, mass spectrometry under reducing/non-reducing conditions\",\n      \"pmids\": [\"23990400\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ER chaperones mediating the ratchet not identified\", \"Quantitative kinetics of assembly steps lacking\", \"Single-lab biochemical model\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Adiponectin was shown to signal through AdipoR1→AMPK→SIRT1→PGC-1α to suppress NF-κB-driven muscle inflammation in dystrophin-deficient mice, and its transcriptional induction in adipocytes was linked to an osteocalcin→GPRC6A→cAMP/PKA→ERK→CREB→PPARγ cascade, expanding both downstream effector and upstream regulatory pathways.\",\n      \"evidence\": \"Adiponectin transgenic × mdx cross with pathway western blots, grip strength, Evans Blue Dye assay, human myotubes; GluOC-treated 3T3-L1 with signaling inhibitors and PPARγ/CREB reporter assays in mice\",\n      \"pmids\": [\"26257862\", \"25562427\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SIRT1-PGC-1α axis is required in non-dystrophic muscle unknown\", \"Osteocalcin-adiponectin axis not validated in human physiology\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"An antisense lncRNA transcribed from the ADIPOQ locus was found to form an RNA duplex with ADIPOQ mRNA in the cytoplasm to repress its translation, revealing a cis-regulatory post-transcriptional control mechanism for adiponectin production.\",\n      \"evidence\": \"RNA duplex detection, nuclear-cytoplasmic fractionation, adenoviral lncRNA delivery in HFD mice with adipose and liver triglyceride measurements\",\n      \"pmids\": [\"29414510\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"lncRNA regulation during obesity in humans not tested\", \"Whether duplex formation affects mRNA stability vs. ribosome loading not distinguished\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Complementary knockout and transgenic overexpression lifespan studies established adiponectin as a determinant of organismal healthspan, with loss accelerating age-related metabolic decline and excess extending median lifespan.\",\n      \"evidence\": \"Adiponectin KO and transgenic mice on chow and HFD with metabolic phenotyping, tissue histology for inflammation/fibrosis, and survival analysis\",\n      \"pmids\": [\"33904399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking adiponectin to lifespan extension (beyond insulin sensitization) not defined\", \"Human genetic evidence for longevity effect lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic-resolution structural basis for oligomer-specific receptor engagement, the mechanism by which APPL1 couples AdipoR1 to AMPK activation, whether the antisense lncRNA regulatory mechanism operates in human adipose tissue, and what tissue-specific signaling complexes beyond the cardiac AdipoR1/Cav-3 module exist.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No co-crystal structure of adiponectin oligomer bound to AdipoR1/R2\", \"APPL1-to-AMPK signaling intermediates not identified\", \"Antisense lncRNA mechanism not confirmed in human systems\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [3, 4, 6, 7, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 5, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 3, 6]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2, 10, 11]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 7, 8, 12, 13, 14, 16]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3, 4, 5, 6, 19]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [6, 18]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [2, 10, 11]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5, 16]}\n    ],\n    \"complexes\": [\n      \"Adiponectin trimer\",\n      \"AdipoR1/Cav-3/APPL1/adenylate cyclase complex\"\n    ],\n    \"partners\": [\n      \"ADIPOR1\",\n      \"ADIPOR2\",\n      \"APPL1\",\n      \"APPL2\",\n      \"CAV3\",\n      \"VTI1A\",\n      \"RAB11A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Adiponectin (ADIPOQ) is an abundant adipocyte-derived secreted hormone that circulates as disulfide-linked trimers, hexamers, and high-molecular-weight (HMW) multimers, each oligomeric species activating distinct signaling cascades: trimers preferentially stimulate AMPK in skeletal muscle to increase fatty-acid oxidation and glucose uptake, while HMW/hexameric forms act on the liver to suppress gluconeogenesis (PEPCK, G6Pase) and activate NF-κB in myocytes [PMID:12368907, PMID:14699128, PMID:14522956]. Adiponectin signals through the seven-transmembrane receptors AdipoR1 (muscle) and AdipoR2 (liver), scaffolded by caveolin-3 and the adaptor APPL1, to activate AMPK→ACC, AMPK→Akt→eNOS (NO production), and cAMP/PKA pathways, thereby exerting insulin-sensitizing, anti-inflammatory, and vasoprotective effects [PMID:12802337, PMID:18854421, PMID:22328772, PMID:12944390]. In the vasculature, adiponectin suppresses TNF-α-induced endothelial adhesion molecule expression via cAMP/PKA-dependent inhibition of NF-κB, reduces macrophage scavenger receptor expression to prevent foam-cell formation, and induces anti-inflammatory cytokines IL-10 and IL-1RA in monocytes/macrophages [PMID:10982546, PMID:11222466, PMID:15369797]. Bidirectional genetic models demonstrate that adiponectin deficiency causes diet-induced insulin resistance and shortened lifespan, while overexpression extends healthspan by reducing systemic inflammation and tissue fibrosis [PMID:12068289, PMID:33904399].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Identification of Acrp30/adiponectin as a novel adipocyte-exclusive secreted protein that forms oligomers and is insulin-regulated established the existence of a major adipokine, opening the question of its physiological function.\",\n      \"evidence\": \"Differential display cloning, Western blot, oligomer characterization, and insulin stimulation in 3T3-L1 adipocytes\",\n      \"pmids\": [\"7592907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biological function unknown\", \"Receptor(s) unidentified\", \"Relevance of oligomeric forms unclear\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Cloning of the full-length cDNA and demonstration that adiponectin expression is reduced in obesity linked the protein to metabolic disease and defined its domain architecture (signal peptide, collagenous domain, C1q-like globular domain).\",\n      \"evidence\": \"mRNA differential display, cDNA cloning, Northern blot in obese vs. lean mice and humans; biochemical purification from human plasma confirming disulfide-linked ~420 kDa oligomers\",\n      \"pmids\": [\"8631877\", \"8947845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of obesity-associated downregulation unknown\", \"No receptor identified\", \"Whether oligomerization is functionally important untested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstration that adiponectin resides in a PI3K-dependent regulated secretory compartment distinct from GLUT4 vesicles revealed that adipocytes actively control adiponectin release; concurrent discovery that adiponectin inhibits TNF-α-induced endothelial adhesion molecules established its anti-inflammatory vascular role.\",\n      \"evidence\": \"Deconvolution microscopy and PI3K inhibitors in 3T3-L1 adipocytes; cell ELISA and monocyte adhesion assay in HAECs\",\n      \"pmids\": [\"10444069\", \"10604883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream endothelial signaling pathway unknown\", \"Secretory compartment identity (recycling endosome vs. other) undefined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Elucidation of the cAMP/PKA-dependent mechanism by which adiponectin suppresses NF-κB (IκB-α phosphorylation) in endothelial cells, and of its ability to reduce macrophage foam-cell formation by downregulating class A scavenger receptor transcription, established the molecular basis for its anti-atherogenic activity.\",\n      \"evidence\": \"EMSA, IκB-α immunoblot, adenylate cyclase/PKA inhibitors in HAECs; scavenger receptor promoter reporter assay, Oil Red O staining, and C1qRp blockade in macrophages\",\n      \"pmids\": [\"10982546\", \"11222466\", \"10961870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the endothelial receptor unknown\", \"Whether C1qRp is a bona fide signaling receptor or merely a binding partner unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"In vivo studies showed adiponectin suppresses hepatic glucose production (reducing PEPCK and G6Pase) and reverses insulin resistance in obese and lipoatrophic mice by decreasing tissue triglyceride content, establishing the liver and muscle as primary metabolic target organs.\",\n      \"evidence\": \"Recombinant adiponectin injection in ob/ob, NOD, and STZ mice; euglycemic clamp; isolated hepatocyte glucose output; triglyceride content assays in muscle/liver\",\n      \"pmids\": [\"11479628\", \"11748271\", \"11479627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream kinase mediating hepatic effects unknown\", \"Receptor identity still missing\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"AMPK was identified as the central kinase mediating adiponectin's metabolic effects — phosphorylating ACC to increase fatty-acid oxidation and glucose uptake — with dominant-negative AMPK blocking all effects; concurrently, adiponectin-knockout mice confirmed in vivo necessity for insulin sensitivity, and structure–function studies showed Cys-39-dependent disulfide bonds govern oligomer assembly and differential bioactivity of trimers vs. HMW forms.\",\n      \"evidence\": \"Dominant-negative AMPK in myocytes/hepatocytes; AMPK/ACC phosphorylation assays; adiponectin-KO mice with viral rescue; Cys-39 mutagenesis with in vivo glucose and hepatocyte glucose output assays; NF-κB reporter with purified oligomeric fractions\",\n      \"pmids\": [\"12368907\", \"12068289\", \"12496257\", \"12087086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor still unidentified\", \"How different oligomers are directed to different receptors unknown\", \"Intracellular adaptor proteins linking receptor to AMPK not discovered\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Expression cloning identified AdipoR1 and AdipoR2 as seven-transmembrane adiponectin receptors mediating AMPK and PPARα activation; T-cadherin was later found as a receptor for hexameric/HMW forms; the AMPK→Akt→eNOS cascade was defined as the mechanism for adiponectin-stimulated NO production and angiogenesis; and PPARγ/RXR binding to a PPRE in the ADIPOQ promoter established the transcriptional regulation of adiponectin itself.\",\n      \"evidence\": \"Expression cloning with siRNA in C2C12 cells; dominant-negative AMPK/Akt epistasis in endothelial cells; EMSA and promoter mutagenesis in adipocytes; retroviral library screen for T-cadherin\",\n      \"pmids\": [\"12802337\", \"12944390\", \"12829629\", \"15210937\", \"14522956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"T-cadherin lacks an intracellular domain — signaling mechanism downstream of T-cadherin unknown\", \"Relative contributions of AdipoR1 vs. AdipoR2 to each tissue response not fully delineated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Routing of adiponectin secretion through Rab11-positive recycling endosomes (with Arf6 contribution) and v-SNARE Vti1a defined the intracellular trafficking pathway controlling adiponectin release from adipocytes.\",\n      \"evidence\": \"Dominant-negative Rab11, endosome ablation, and Brefeldin A in 3T3-L1 adipocytes; siRNA knockdown of Vti1a with secretion and glucose uptake assays\",\n      \"pmids\": [\"16516854\", \"16131485\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dominant-negative Rab11 approach not validated by knockout or rescue\", \"Whether Vti1a acts on the same or parallel pathway as Rab11 unclear\", \"Molecular machinery sorting adiponectin into recycling endosomes not identified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of APPL1 as a direct adaptor bridging AdipoR1/R2 intracellular domains to AMPK activation and insulin sensitization resolved how receptor engagement couples to downstream kinase cascades.\",\n      \"evidence\": \"Co-immunoprecipitation, PTB domain binding, APPL1 knockdown/overexpression with AMPK activity and glucose uptake readouts in skeletal muscle and endothelial cells\",\n      \"pmids\": [\"18854421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether APPL1 is the sole or one of multiple adaptors unknown\", \"Crystal structure of AdipoR–APPL1 complex not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Caveolin-3 was shown to scaffold the AdipoR1–APPL1–adenylate cyclase complex, enabling both AMPK-dependent and AMPK-independent (PKA) cardioprotective signaling, thereby adding a membrane microdomain requirement to the adiponectin signaling model.\",\n      \"evidence\": \"Co-IP and Cav-3 knockout mice with ischemia/reperfusion injury, infarct size measurement, PKA inhibitor studies\",\n      \"pmids\": [\"22328772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Cav-3 scaffolding applies to non-cardiac tissues (e.g. skeletal muscle, endothelium) not tested\", \"Role of lipid raft disruption vs. Cav-3 protein specifically not distinguished\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Osteocalcin was identified as an upstream inducer of adiponectin transcription via GPRC6A→cAMP→PKA→ERK→CREB→PPARγ, establishing a bone–adipose endocrine axis; separately, adiponectin was shown to protect dystrophic muscle through AdipoR1–AMPK–SIRT1–PGC-1α signaling.\",\n      \"evidence\": \"Pharmacological pathway dissection with U0126 and PPARγ reporter in adipocytes; mdx × adiponectin-transgenic mice with force measurement and Evans Blue Dye assay\",\n      \"pmids\": [\"25562427\", \"26257862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether osteocalcin–adiponectin axis is quantitatively relevant in humans unknown\", \"Whether SIRT1–PGC-1α axis is engaged in non-dystrophic muscle contexts unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Bidirectional genetic models (knockout and transgenic overexpression) demonstrated that adiponectin is necessary and sufficient for metabolic healthspan: deficiency shortens lifespan with accelerated inflammation and fibrosis, while elevation extends median lifespan.\",\n      \"evidence\": \"Adiponectin-KO and adiponectin-overexpressing mice on chow and HFD, glucose/lipid tolerance, tissue fibrosis quantification, lifespan analysis\",\n      \"pmids\": [\"33904399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific tissue(s) responsible for lifespan extension not identified\", \"Whether chronic adiponectin elevation has detrimental effects in other contexts (e.g. cancer) not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How T-cadherin, which lacks an intracellular domain, transduces hexameric/HMW adiponectin signals remains mechanistically unresolved; the structural basis of oligomer-specific receptor selectivity and the full spectrum of tissue-specific adaptor complexes downstream of AdipoR1/R2 are also unknown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"T-cadherin signaling mechanism completely undefined\", \"No crystal structure of full-length AdipoR–adiponectin complex\", \"Relative in vivo contributions of AdipoR1, AdipoR2, and T-cadherin to specific metabolic outcomes not genetically dissected in parallel\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 8, 9, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 6, 11, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 2, 17]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3, 26]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 11, 15, 18, 27, 30]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [9, 10, 11, 12]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 5, 6, 7, 22]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 13, 16]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [11, 12]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [3, 25, 26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ADIPOR1\",\n      \"ADIPOR2\",\n      \"CDH13\",\n      \"APPL1\",\n      \"CAV3\",\n      \"VTI1A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}